Literature DB >> 11314005

Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability.

C Guiducci1, M A Cerone, S Bacchetti.   

Abstract

We have reconstituted wild type or mutant telomerase activity in two human cell lines that lack constitutive expression of both core subunits of the enzyme and maintain telomeres by a telomerase-independent mechanism (ALT cells). Wild type telomerase RNA and four telomerase RNAs with single point mutations in their template domain were used to express enzymes specifying different telomeric DNA sequences. Expression of wild type telomerase for up to 32 days had no detectable effect on cell growth or viability. In contrast, cells expressing mutant telomerases had slower growth rate, abnormal cell cycle and reduced viability. Dramatically aberrant nuclei, typical of cells undergoing mitotic catastrophe, and large numbers of fused chromosomes were also characteristic of these populations. Notably, all phenotypes were apparent within the first few cell divisions after expression of the enzymes. Unlike wild type, mutant telomerase activity was progressively selected against with cell culturing, and this correlated with the disappearance of cells with aberrant phenotypes. Our results suggest that even very limited synthesis of mutated sequences can affect telomere structure in human cells, and that the toxicity of mutant telomerases is due to telomere malfunction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11314005     DOI: 10.1038/sj.onc.1204145

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

Review 1.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands.

Authors:  J F Riou; L Guittat; P Mailliet; A Laoui; E Renou; O Petitgenet; F Mégnin-Chanet; C Hélène; J L Mergny
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

Review 3.  Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology.

Authors:  J Fajkus; M Simícková; J Maláska
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

Review 4.  Such small hands: the roles of centrins/caltractins in the centriole and in genome maintenance.

Authors:  Tiago J Dantas; Owen M Daly; Ciaran G Morrison
Journal:  Cell Mol Life Sci       Date:  2012-03-30       Impact factor: 9.261

5.  A self-regulating template in human telomerase.

Authors:  Andrew F Brown; Joshua D Podlevsky; Xiaodong Qi; Yinnan Chen; Mingyi Xie; Julian J-L Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

6.  The terminal telomeric DNA sequence determines the mechanism of dysfunctional telomere fusion.

Authors:  Bradley A Stohr; Lifeng Xu; Elizabeth H Blackburn
Journal:  Mol Cell       Date:  2010-07-30       Impact factor: 17.970

7.  Loss of cap structure causes mitotic defect in Tetrahymena thermophila telomerase mutants.

Authors:  Marina Petcherskaia; Jennifer M McGuire; James M Pherson; Karen E Kirk
Journal:  Chromosoma       Date:  2003-03-11       Impact factor: 4.316

8.  A novel pseudoknot element is essential for the action of a yeast telomerase.

Authors:  Yehuda Tzfati; Zachary Knight; Jagoree Roy; Elizabeth H Blackburn
Journal:  Genes Dev       Date:  2003-06-27       Impact factor: 11.361

9.  A centrosome-autonomous signal that involves centriole disengagement permits centrosome duplication in G2 phase after DNA damage.

Authors:  Burcu Inanç; Helen Dodson; Ciaran G Morrison
Journal:  Mol Biol Cell       Date:  2010-09-22       Impact factor: 4.138

10.  ATM mediates cytotoxicity of a mutant telomerase RNA in human cancer cells.

Authors:  Bradley A Stohr; Elizabeth H Blackburn
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.